Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice.
Mol Ther Oncolytics
; 30: 238-253, 2023 Sep 21.
Article
in En
| MEDLINE
| ID: mdl-37701849
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Ther Oncolytics
Year:
2023
Document type:
Article
Affiliation country:
Alemania